Ambryon Biosciences

MyoAAV-4A Serotype

Fourth myoAAV variant from M-CREATE selection, completing the muscle-targeted AAV toolkit with distinct properties.

TropismSkeletal muscle, cardiac muscle, cross-species validated

Characteristics

Additional M-CREATE isolate with unique characteristics. Balanced skeletal and cardiac muscle transduction. Cross-species validation. Alternative pharmacology to other myoAAV variants.

Applications

Multi-muscle tissue gene therapy. Systemic muscular dystrophy treatments. Translational applications.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Tabebordbar et al. (2021). Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell — Tabebordbar 2021 MyoAAV

Identifiers & revision